Welcome to our dedicated page for Diversified Healthcare Tr SEC filings (Ticker: DHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Understanding Diversified Healthcare Trust’s dual real-estate strategy in medical offices and senior living can quickly turn into a 300-page puzzle of lease terms, REIT tax rules, and healthcare regulations. If you have ever typed “Where can I find Diversified Healthcare Trust’s quarterly earnings reports?” or searched for “Diversified Healthcare Trust insider trading Form 4 transactions,” you know how scattered EDGAR can feel. Stock Titan’s AI-powered analysis brings every disclosure into one streamlined view and highlights what matters most.
Our platform captures each document the instant it posts—10-K, 10-Q, 8-K, S-11, and every Form 4—and turns legal language into plain English. Need the essence of the latest “Diversified Healthcare Trust quarterly earnings report 10-Q filing”? We extract segment NOI, occupancy trends, and rent coverage in seconds. Tracking “Diversified Healthcare Trust Form 4 insider transactions real-time” or “Diversified Healthcare Trust executive stock transactions Form 4”? Instant alerts show who bought, who sold, and why it matters. Even the dense “Diversified Healthcare Trust proxy statement executive compensation” is condensed so you can see pay-for-performance metrics without scrolling for hours.
Because REIT performance hinges on property-level cash flow, our AI correlates data across forms. The “Diversified Healthcare Trust annual report 10-K simplified” links SHOP occupancy to the very filing that announced a new management agreement, letting you grasp why the “Diversified Healthcare Trust 8-K material events explained” could move FFO. If your goal is “Diversified Healthcare Trust SEC filings explained simply,” or you need a quick “Diversified Healthcare Trust earnings report filing analysis,” Stock Titan replaces hours of manual reading with clear, searchable insight. Start understanding Diversified Healthcare Trust SEC documents with AI today.
Diversified Healthcare Trust reported Q3 2025 results. Total revenues were $388.706 million, led by resident fees and services of $333.390 million and rental income of $55.316 million. The quarter posted a net loss of $164.040 million (−$0.68 per share), reflecting $93.243 million of impairment charges, interest expense of $48.886 million, and an $11.191 million loss on early debt actions.
Year to date, revenue reached $1.158 billion with a net loss of $264.665 million. The company sold 32 properties for $353.675 million, recording gains of $103.971 million, and classified 50 properties as held for sale. Subsequent to quarter-end, 12 more properties were sold for $42.130 million.
DHC refinanced and reduced near-term debt: it redeemed the entire $380 million 9.75% senior notes due June 2025, issued $375 million of 7.25% senior secured notes due 2030, and partially redeemed senior secured notes due 2026, leaving $334.370 million outstanding. Cash and cash equivalents were $201.371 million. Total assets were $4.684 billion and equity was $1.689 billion as of September 30, 2025.
Diversified Healthcare Trust furnished an update on its business by announcing financial results for the quarter ended September 30, 2025. The company provided a summary press release and a detailed earnings presentation to accompany the results, making them available as Exhibits 99.1 and 99.2. This 8‑K is limited to distributing those materials and does not itself include the underlying figures.
DIVERSIFIED HEALTHCARE TRUST filed an 8-K reporting the execution of an indenture dated
The report is signed by Matthew C. Brown, Chief Financial Officer and Treasurer, indicating the company completed the documentation for the secured note issuance structure described in the filing.
Matthew C. Brown, the Chief Financial Officer and Treasurer of Diversified Healthcare Trust (ticker DHC), reported a sale of common shares on 09/16/2025. The Form 4 shows 9,711 shares were disposed of at a reported price of $4.37 per share, reducing his beneficial ownership to 113,954 shares. The filing states the disposition code is F(1), and the explanatory note says the transaction represents withholding of shares to satisfy tax withholding obligations upon vesting.
This filing is a routine insider tax-withholding sale rather than an open-market trade, and it was signed by Mr. Brown on 09/18/2025.
Christopher J. Bilotto, who serves as President and CEO and a director of Diversified Healthcare Trust (ticker shown in filing as NASDAQ:DHC), reported a transaction on 09/16/2025 disposing of 17,091 common shares at a price of $4.37 per share. The filing states the shares were withheld to pay a tax liability related to the vesting of previously issued securities. After the withholding, the report shows 245,899.89 common shares beneficially owned by Mr. Bilotto. The Form 4 is signed by the reporting person for this single-person filing.
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ: DHC), reported a sale of 15,226 common shares on 09/16/2025 at a price of $4.37 per share. The filing lists 415,156.55 shares as his direct beneficial ownership following the transaction and indicates an indirect interest of 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee; he disclaims beneficial ownership except to the extent of his pecuniary interest. The filing explains the sale code as F, reflecting withholding of shares to satisfy a tax liability arising from vesting. The Form 4 was signed on 09/18/2025.
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ:DHC), reported an equity award and resulting holdings. On 09/09/2025 Mr. Portnoy was awarded 81,775 common shares under the issuer's equity compensation plan, a transaction he reported on Form 4 with his signature dated 09/11/2025.
Following the award the filing shows 430,382.55 common shares listed as beneficially owned following the reported transaction and separately discloses 23,250,019 shares held by ABP Trust, of which Mr. Portnoy is sole trustee and which he may be deemed to beneficially own though he disclaims ownership except for his pecuniary interest.
Christopher J. Bilotto, President and CEO and a director of Diversified Healthcare Trust (NASDAQ: DHC), reported an equity award and additional share acquisitions. On 09/09/2025 Mr. Bilotto was awarded 81,775 common shares under the issuer's equity compensation plan. Following the award and prior reported activity, he beneficially owned 262,990.89 shares. The filing also notes 394.05 shares were acquired under a dividend reinvestment plan since his last Section 16 filing.
This Form 4 discloses a routine, compensation-related share award and reinvested dividends that increase an insider's stake; the report was signed on 09/11/2025.
Matthew C. Brown, CFO and Treasurer of Diversified Healthcare Trust (NASDAQ: DHC), received an award of 37,383 common shares under the issuer's equity compensation plan. After the award, his beneficial ownership in the company's common shares increased to 123,665 shares. The transaction is reported as an acquisition and reflects equity compensation rather than an open-market purchase or sale.
FAQ
What is the current stock price of Diversified Healthcare Tr (DHC)?
What is the market cap of Diversified Healthcare Tr (DHC)?
